NCT03556059

Brief Summary

The Edmonton Obesity Staging System (EOSS) is a more comprehensive measure of obesity-related diseases and predictor of mortality than BMI or waist circumference. EOSS is also important in predicting post - operative outcome and 30-day mortality after metabolic surgery. The aim of this study is to determine whether EOSS could be an indicator for procedure selection in obesity and metabolic surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9,437

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2015

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

May 18, 2018

Completed
27 days until next milestone

First Posted

Study publicly available on registry

June 14, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

January 24, 2019

Status Verified

January 1, 2019

Enrollment Period

3.8 years

First QC Date

May 18, 2018

Last Update Submit

January 21, 2019

Conditions

Keywords

EOSSObesity and metabolic surgerypostoperative outcomeprocedure selection

Outcome Measures

Primary Outcomes (1)

  • postoperative complications

    postoperative outcome after surgery next to the Clavien Dindo Classification

    30 days after surgery

Secondary Outcomes (13)

  • postoperative complications related to surgical procedure

    30 days after surgery

  • postoperative complications related to Edmonton Obesity Staging System

    30 days after surgery

  • ASA related to Edmonton Obesity Staging System

    prior to surgery

  • Edmonton Obesity Staging System related to length of postoperative stay

    30 days after surgery

  • Edmonton Obesity Staging System related to readmission

    30 days after surgery

  • +8 more secondary outcomes

Study Arms (3)

RNYGB

ACTIVE COMPARATOR

The role of EOSS for the surgical intervention: Roux-en-Y gastric bypass for severe obesity

Other: Role of EOSS

Sleeve

ACTIVE COMPARATOR

The role of EOSS for the surgical intervention: Sleeve Gastrectomy for severe obesity

Other: Role of EOSS

MGB/OAGB

ACTIVE COMPARATOR

The role of EOSS for the surgical intervention: Mini/One anastomosis gastric bypass for severe obesity

Other: Role of EOSS

Interventions

The Edmonton Obesity Staging System (EOSS) is a more comprehensive measure of obesity-related diseases and predictor of mortality than body mass index (BMI) or waist circumference. Its application for the selection of obese patients for obesity surgery has been suggested. This study evaluates the role of the Edmonton Obesity Staging System (EOSS) in predicting postoperative outcome (next to the Clavien Dindo Classification) and 30-day mortality after metabolic surgery.

MGB/OAGBRNYGBSleeve

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sleeve for severe obesity RNYGB for severe obesity MGB/OAGB for severe obesity

You may not qualify if:

  • previous obesity surgery
  • previous surgery of the upper gastrointestinal tract in anamnesis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sana Klinikum Offenbach

Offenbach, 63069, Germany

Location

Related Publications (6)

  • Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes (Lond). 2009 Mar;33(3):289-95. doi: 10.1038/ijo.2009.2. Epub 2009 Feb 3.

  • Kuk JL, Ardern CI, Church TS, Sharma AM, Padwal R, Sui X, Blair SN. Edmonton Obesity Staging System: association with weight history and mortality risk. Appl Physiol Nutr Metab. 2011 Aug;36(4):570-6. doi: 10.1139/h11-058. Epub 2011 Aug 14.

  • Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ. 2011 Oct 4;183(14):E1059-66. doi: 10.1503/cmaj.110387. Epub 2011 Aug 15.

  • Gill RS, Karmali S, Sharma AM. The potential role of the Edmonton obesity staging system in determining indications for bariatric surgery. Obes Surg. 2011 Dec;21(12):1947-9. doi: 10.1007/s11695-011-0533-8. No abstract available.

  • Chiappetta S, Stier C, Squillante S, Theodoridou S, Weiner RA. The importance of the Edmonton Obesity Staging System in predicting postoperative outcome and 30-day mortality after metabolic surgery. Surg Obes Relat Dis. 2016 Dec;12(10):1847-1855. doi: 10.1016/j.soard.2016.02.042. Epub 2016 Mar 2.

  • Chiappetta S, Stier C, Weiner RA; members of StuDoQ|MBE of Deutsche Gesellschaft fur Allgemein- und Viszeralchirurgie/StuDoQ. The Edmonton Obesity Staging System Predicts Perioperative Complications and Procedure Choice in Obesity and Metabolic Surgery-a German Nationwide Register-Based Cohort Study (StuDoQ|MBE). Obes Surg. 2019 Dec;29(12):3791-3799. doi: 10.1007/s11695-019-04015-y.

MeSH Terms

Conditions

Postoperative ComplicationsObesity

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and Symptoms

Study Officials

  • Rudolf Weiner, Prof.

    Sana Klinikum Offenbach

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: A cohort of all patients who underwent obesity and metabolic surgery in Germany will be analyzed in relation to preoperative complications
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior consultant, Principal Investigator, MD

Study Record Dates

First Submitted

May 18, 2018

First Posted

June 14, 2018

Study Start

February 1, 2015

Primary Completion

December 1, 2018

Study Completion

December 1, 2018

Last Updated

January 24, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Anonymous data will be published in a peer-reviewed journal.

Locations